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URETHRAL STENT (MEMOTHERM⑧) FOR THE TREATMENT 
OF BENIGN PROSTATIC HYPERPLASIA 
Yasuteru NODA， Takeshi UJIKE， Daizo OKA， 
Shingo T AKADA， Nobumasa FU]IMOTO and Takuo KOIDE 
From the Department 01 Uro!ogy， Osaka Kosei-nenkin Hospita! 
We used a urethral stent for management ofhigh-age and high-risk patients with benign prostatic 
hyperplasia (BPH) who needed surgical therapy. Nine patients were treated by this method. Chief 
complaints were urinary retention in 6 patients， dysuria with much residual urine in 2 and dysuria in 1. 
Blood loss and complications ofthe method were minima!. Postoperatively， 8 ofthe patients were able 
to void and on the average， residual urine of the patients was approximately 10m!. Implantation of 
the urethral stent is a safe and non-invasive therapy for the patients who are unsuitable for invasive 
therapy. 
(Acta Uro!. Jpn. 49: 645-647， 2003) 













































Characteristics of nine patients， results and complications 
勝脱使用長手術時間出血量術中
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Urethrocystography in one month after operation. Fig. 1. 
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